Quadrant Capital Group’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $239K | Hold |
3,662
| – | – | 0.01% | 1232 |
|
|
2025
Q1 | $245K | Buy |
3,662
+3,650
| +30,417% | +$244K | 0.01% | 1193 |
|
|
2024
Q4 | $664 | Hold |
12
| – | – | ﹤0.01% | 2625 |
|
|
2024
Q3 | $716 | Hold |
12
| – | – | ﹤0.01% | 2629 |
|
|
2024
Q2 | $765 | Hold |
12
| – | – | ﹤0.01% | 2588 |
|
|
2024
Q1 | $830 | Hold |
12
| – | – | ﹤0.01% | 2607 |
|
|
2023
Q4 | $662 | Hold |
12
| – | – | ﹤0.01% | 2596 |
|
|
2023
Q3 | $697 | Hold |
12
| – | – | ﹤0.01% | 2528 |
|
|
2023
Q2 | $646 | Hold |
12
| – | – | ﹤0.01% | 2543 |
|
|
2023
Q1 | $477 | Sell |
12
-12
| -50% | -$477 | ﹤0.01% | 2611 |
|
|
2022
Q4 | $966 | Sell |
24
-6
| -20% | -$242 | ﹤0.01% | 2554 |
|
|
2022
Q3 | $1K | Sell |
30
-13
| -30% | -$433 | ﹤0.01% | 2464 |
|
|
2022
Q2 | $1K | Buy |
43
+14
| +48% | +$326 | ﹤0.01% | 2316 |
|
|
2022
Q1 | $1K | Sell |
29
-22
| -43% | -$759 | ﹤0.01% | 2239 |
|
|
2021
Q4 | $2K | Buy |
51
+25
| +96% | +$980 | ﹤0.01% | 2100 |
|
|
2021
Q3 | $1K | Buy |
+26
| New | +$1K | ﹤0.01% | 2236 |
|